BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25731880)

  • 1. Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.
    Reuschenbach M; Huebbers CU; Prigge ES; Bermejo JL; Kalteis MS; Preuss SF; Seuthe IM; Kolligs J; Speel EJ; Olthof N; Kremer B; Wagner S; Klussmann JP; Vinokurova S; von Knebel Doeberitz M
    Cancer; 2015 Jun; 121(12):1966-76. PubMed ID: 25731880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.
    Cheung JL; Cheung TH; Yu MY; Chan PK
    Gynecol Oncol; 2013 Nov; 131(2):374-9. PubMed ID: 24012799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV 16 E2 binding sites 1 and 2 become more methylated than E2 binding site 4 during cervical carcinogenesis.
    Leung TW; Liu SS; Leung RC; Chu MM; Cheung AN; Ngan HY
    J Med Virol; 2015 Jun; 87(6):1022-33. PubMed ID: 25648229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation at 3'LCR of HPV16 can be affected by patient age and disruption of E1 or E2 genes.
    Filho SMA; Bertoni N; Brant AC; Vidal JPCB; Felix SP; Cavalcanti SMB; Carestiato FN; Martins LFL; Almeida LM; Moreira MAM
    Virus Res; 2017 Mar; 232():48-53. PubMed ID: 28143725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions.
    Chaiwongkot A; Vinokurova S; Pientong C; Ekalaksananan T; Kongyingyoes B; Kleebkaow P; Chumworathayi B; Patarapadungkit N; Reuschenbach M; von Knebel Doeberitz M
    Int J Cancer; 2013 May; 132(9):2087-94. PubMed ID: 23065631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
    Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
    Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2.
    Bhattacharjee B; Sengupta S
    Virology; 2006 Oct; 354(2):280-5. PubMed ID: 16905170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus does not have a causal role in colorectal carcinogenesis.
    Lorenzon L; Mazzetta F; Pilozzi E; Uggeri G; Torrisi MR; Ferri M; Ziparo V; French D
    World J Gastroenterol; 2015 Jan; 21(1):342-50. PubMed ID: 25574110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
    Zheng Y; Peng ZL; Lou JY; Wang H
    Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
    Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
    PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
    Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
    J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection.
    Kim K; Garner-Hamrick PA; Fisher C; Lee D; Lambert PF
    J Virol; 2003 Dec; 77(23):12450-9. PubMed ID: 14610169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas.
    Barbieri D; Nebiaj A; Strammiello R; Agosti R; Sciascia S; Gallinella G; Landini MP; Caliceti U; Venturoli S
    J Clin Virol; 2014 Jul; 60(3):243-9. PubMed ID: 24845262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.
    Amaro-Filho SM; Pereira Chaves CB; Felix SP; Basto DL; de Almeida LM; Moreira MAM
    Papillomavirus Res; 2018 Jun; 5():172-179. PubMed ID: 29649654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions.
    Yoshida T; Sano T; Kanuma T; Owada N; Sakurai S; Fukuda T; Nakajima T
    Int J Gynecol Cancer; 2008; 18(1):121-7. PubMed ID: 17506843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.
    Jacquin E; Baraquin A; Ramanah R; Carcopino X; Morel A; Valmary-Degano S; Bravo IG; de Sanjosé S; Riethmuller D; Mougin C; Prétet JL
    J Clin Microbiol; 2013 Oct; 51(10):3207-15. PubMed ID: 23863566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
    Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
    Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes.
    Fontan CT; Das D; Bristol ML; James CD; Wang X; Lohner H; Atfi A; Morgan IM
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33298572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
    Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
    Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of viral E2-gene status on outcome after radiotherapy for patients with human papillomavirus 16-positive cancer of the uterine cervix.
    Lindel K; de Villiers EM; Burri P; Studer U; Altermatt HJ; Greiner RH; Gruber G
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):760-5. PubMed ID: 16682151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.